0789 Neutrophilic eccrine hidradenitis following mirvetuximab soravtansine extravasation: First reported case
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S137
DOI: 10.1016/j.jid.2026.06.820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von K. Bai und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bai, K., Karagenova, R., Zimmerman, H., Stenger, K., Liao, L., Lee, D., Phan, C., Elpern, D., & Johnson, D. (2026). 0789 Neutrophilic eccrine hidradenitis following mirvetuximab soravtansine extravasation: First reported case. Journal of Investigative Dermatology, 146(8), S137. https://doi.org/10.1016/j.jid.2026.06.820
Vancouver
Bai K, Karagenova R, Zimmerman H, Stenger K, Liao L, Lee D, et al. 0789 Neutrophilic eccrine hidradenitis following mirvetuximab soravtansine extravasation: First reported case. Journal of Investigative Dermatology. 2026;146(8):S137. doi:10.1016/j.jid.2026.06.820
BibTeX
@article{Bai2026,
author = {Bai, K. and Karagenova, R. and Zimmerman, H.M. and Stenger, K. and Liao, L. and Lee, D.E. and Phan, C.M. and Elpern, D.J. and Johnson, D.W.},
title = {0789 Neutrophilic eccrine hidradenitis following mirvetuximab soravtansine extravasation: First reported case},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S137},
doi = {10.1016/j.jid.2026.06.820}
}
EUVIMED